Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry Exchange Traded Fund Units
No trades
Key stats
About Tibet Eastmoney CSI SH-HK-SZ Brand Name Drug Industry Exchange Traded Fund Units
Home page
Inception date
Apr 21, 2023
Structure
Open-Ended Fund
CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross
Dividend treatment
Distributes
Primary advisor
Tibet Dongcai Fund Management Co., Ltd.
ISIN
CNE100005YZ1
Tightly track the target index, pursue the minimization of tracking deviation and tracking err.
Classification
Returns
| 1 month | 3 months | Year to date | 1 year | 3 years | 5 years | |
|---|---|---|---|---|---|---|
| Price performance | — | — | — | — | — | — |
| NAV total return | — | — | — | — | — | — |
What's in the fund
Exposure type
Health Technology
Stocks88.79%
Health Technology87.90%
Commercial Services0.89%
Bonds, Cash & Other11.21%
Miscellaneous9.41%
Cash1.80%
Stock breakdown by region
Asia98.43%
Europe1.57%
North America0.00%
Latin America0.00%
Africa0.00%
Middle East0.00%
Oceania0.00%
Top 10 holdings
Dividends
Dividend payout history
Assets under management (AUM)
Fund Flows
Frequently Asked Questions
159622 invests in stocks. The fund's major sectors are Health Technology, with 87.90% stocks, and Commercial Services, with 0.89% of the basket. The assets are mostly located in the Asia region.
159622 top holdings are WuXi AppTec Co., Ltd. Class A and Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A, occupying 9.97% and 9.94% of the portfolio correspondingly.
No, 159622 doesn't pay dividends to its holders.
159622 shares are issued by Tibet Oriental Wealth Securities Co., Ltd. under the brand Dongcai. The ETF was launched on Apr 21, 2023, and its management style is Passive.
159622 expense ratio is 0.55% meaning you'd have to pay 0.55% of your investment to help manage the fund.
159622 follows the CSI Shanghai-Hong Kong-Shenzhen Innovative Drug Industry Index - CNY - Benchmark TR Gross. ETFs usually track some benchmark seeking to replicate its performance and guide asset selection and objectives.
159622 invests in stocks.